Research
Energy balance
Current glucose-lowering therapies for Type 2 diabetes show no benefit in reducing the risk of macrovascular events.
Clinicians should reconsider the reliance on glucose-lowering therapies for cardiovascular protection.
StrongRefutesmedium confidence
Large clinical trials of current glucose-lowering therapies for Type 2 diabetes have shown no benefit in reducing the risk of macrovascular events.
Why this rating
Based on the context of large clinical trials.
Source
Contemporary treatment strategies for Type 2 diabetes-related macrovascular disease
Andrew MN Walker et al. · Expert Review of Endocrinology & Metabolism · 2014
DOI 10.1586/17446651.2014.941356
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →